156 related articles for article (PubMed ID: 19031228)
1. Changes to spontaneous otoacoustic emissions (SOAEs) due to cisplatin administration.
Kuroda T; Chida E; Kashiwamura M; Matsumura M; Fukuda S
Int J Audiol; 2008 Nov; 47(11):695-701. PubMed ID: 19031228
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops.
Haginomori SI; Makimoto K; Tanaka H; Araki M; Takenaka H
Laryngoscope; 2001 Jan; 111(1):96-101. PubMed ID: 11192908
[TBL] [Abstract][Full Text] [Related]
3. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
[TBL] [Abstract][Full Text] [Related]
4. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
5. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
6. Clinical investigation on spontaneous otoacoustic emission (SOAE) in 447 ears.
Kuroda T
Auris Nasus Larynx; 2007 Mar; 34(1):29-38. PubMed ID: 17116381
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
8. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
[TBL] [Abstract][Full Text] [Related]
9. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
10. Ototoxic impact of cisplatin in pediatric oncology patients.
Berg AL; Spitzer JB; Garvin JH
Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
[TBL] [Abstract][Full Text] [Related]
11. Sequence variations of mitochondrial DNA and individual sensitivity to the ototoxic effect of cisplatin.
Peters U; Preisler-Adams S; Lanvers-Kaminsky C; Jürgens H; Lamprecht-Dinnesen A
Anticancer Res; 2003; 23(2B):1249-55. PubMed ID: 12820379
[TBL] [Abstract][Full Text] [Related]
12. Objective evaluation of the effects of intravenous lidocaine on tinnitus.
Kalcioglu MT; Bayindir T; Erdem T; Ozturan O
Hear Res; 2005 Jan; 199(1-2):81-8. PubMed ID: 15574302
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous otoacoustic emissions in two infants.
Kaga K; Akamatsu Y; Nakamura M; Sakata H
Acta Otolaryngol; 2009 Apr; 129(4):399-404. PubMed ID: 19085522
[TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions.
Riga M; Korres S; Psarommatis I; Varvutsi M; Giotakis I; Papadas T; Ferekidis E; Apostolopoulos N
Otol Neurotol; 2007 Feb; 28(2):208-12. PubMed ID: 17255889
[TBL] [Abstract][Full Text] [Related]
15. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
16. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
17. Distortion product otoacoustic emission for the screening of cochlear damage in children treated with cisplatin.
Al-Noury K
Laryngoscope; 2011 May; 121(5):1081-4. PubMed ID: 21495043
[TBL] [Abstract][Full Text] [Related]
18. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
[TBL] [Abstract][Full Text] [Related]
19. Characterization of spontaneous otoacoustic emissions in full-term newborns.
Qi B; Cheng X; En H; Huang L; Zhang L
Int J Pediatr Otorhinolaryngol; 2014 Dec; 78(12):2286-91. PubMed ID: 25468465
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous otoacoustic emissions and sensori-neural hearing loss.
Moulin A; Collet L; Delli D; Morgon A
Acta Otolaryngol; 1991; 111(5):835-41. PubMed ID: 1759568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
